U.S. Trade Distributors Stock News

Bandwidth stock has delivered a very strong 223.7% return over the past year, but the valuation checks and current market multiples suggest the shares are not obviously cheap at today’s price of US$43.47. Over the last 12 months, Bandwidth has returned 223.7%, which puts current investors in a position where expectations for future performance are already a big part of the price. The key support for the current valuation can come from Bandwidth’s ability to turn revenue into consistent cash...

Rising inflation, hawkish comments from Federal Reserve officials and uncertainty around the next move on interest rates are reshaping how investors think about banks and insurers. Some stocks could benefit if higher rates support lending margins or investment income, while others may face pressure from funding costs and credit risks. This article focuses on three stocks from our Financial Sector screener that appear closely tied to these rate and policy trends. You will see how each stock is...

AES stock is back in focus as a potential takeover and a long term share price decline of 26.1% over five years meet a set of valuation checks that currently lean cheap, including an intrinsic value estimate from a Discounted Cash Flow (DCF) that points to meaningful upside versus the market price. Over the past five years, AES shares have declined 26.1%, which keeps the stock trading well below where longer term holders bought in and puts more weight on whether today’s price offers a margin...

FedEx stock has returned 76.0% over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples currently lean toward the shares trading below what the fundamentals imply. That sets up an important check for investors on whether the recent gains have simply closed a gap or if the market is still pricing FedEx cautiously. FedEx has gained 76.0% over the past year, which puts the current share price in sharp focus against its underlying earnings power...

In July 2026, AtriCure, Inc. reported second-quarter results showing higher revenue of US$153.6 million and a shift from a net loss to net income of US$8.96 million, alongside new full-year 2026 guidance projecting revenue of US$602 million to US$610 million and net income per share of US$0.05 to US$0.13. On the same day, AtriCure also filed two ESOP-related shelf registrations for up to 2,250,000 common shares totaling US$78.84 million, highlighting both improving profitability and plans to...

The market just marked TG Therapeutics down hard, with the stock dropping about 11% the day after earnings, even as the core multiple sclerosis drug story looked stronger on the surface. Investors came in after a solid 12 month run, only to be met with an earnings print that paired powerful BRIUMVI revenue of about US$228 million with a sharp hit to bottom line profit. The headline this quarter is margin pressure. Heavy manufacturing related charges cut reported net income to US$7.8 million...

Ocular Therapeutix stock inched up about 3% to US$8.40 after earnings, a modest move for a biotech that has been drifting lower over the past quarter. The headline is not about a sudden swing into profit. It is about how much revenue growth investors are willing to pay for when the losses remain heavy. Quarterly revenue sat in the low teens in millions of US dollars, while net loss stayed deep in the tens of millions. That mix keeps the spotlight on the long term. For anyone looking at Ocular...

Lantheus Holdings stock has delivered very strong returns over the past few years, yet the current price sits close to the agreed cash offer from Curium, which raises questions about how much upside is left in the valuation. Over the past 5 years, Lantheus Holdings has returned about 294.0%, which puts recent share price moves into the context of a very strong multi year run. The agreed Curium acquisition, with a headline value of up to US$8b tied to milestones, can anchor expectations for...

Compugen stock barely flinched after earnings, ticking up about 1% to US$2.38, yet the real story sits far beyond today’s modest move. You are looking at a biotech that has just posted another small quarter of revenue at US$2.6m and a quarterly net loss of about US$7m, while still carrying a price tag of only 6.4x trailing earnings. The time horizon is the tension. In the short term, Q2 is about controlled burn and a long cash runway into 2029. Over multiple years, the debate shifts to...

Ryerson Holding Corporation recently reported past second-quarter 2026 results, with sales of US$2.01 billion and net income of US$15.5 million, while also declaring a quarterly cash dividend of US$0.1875 per share payable on September 17, 2026. Alongside this, the company issued third-quarter guidance targeting net income of US$19 million to US$21 million and net sales of US$1.87 billion to US$1.95 billion, offering investors a clearer view of its near-term earnings outlook. With this new...

Lindblad Expeditions Holdings stock jumped almost 12% to $33.12 after the Q2 print, capping a strong run over the past three months. The move reflects how quickly investors rewarded a clearer story around profitability. Q2 revenue came in at about $199.2 million, with adjusted earnings before interest, tax, depreciation and amortization margin at 16.3%, and occupancy at 91% on its expedition sailings. The excitement sits against a tougher backdrop. Lindblad remains loss making on a trailing...

Sally Beauty Holdings walked into this report priced as a discounted, debt‑laden specialty retailer. The stock had already climbed over the past month, and the real jolt came today with a 7.8% jump to US$16.13 after earnings hit the tape. The headline is simple: profit quality surprised in a business many investors still treat as ex growth. Adjusted earnings per share landed around the mid US$0.50s and trailing twelve month earnings reached just under US$2 per share, while net profit margin...

ExxonMobil Holdings (NYSE:XOM) executives warn that global refining bottlenecks, worsened by conflicts involving Russia and in the Middle East, could keep fuel prices elevated even if crude oil prices soften. Chevron issues similar caution on refining capacity, reinforcing concerns about a prolonged period of higher fuel costs for end consumers. Former President Donald Trump publicly criticizes ExxonMobil for what he describes as excessive wartime profits linked to the current conflict with...

Federal Agricultural Mortgage Corporation reported past second-quarter 2026 results, with net income of US$66.95 million and diluted earnings per share from continuing operations rising to US$5.41, alongside stronger figures for the first half of the year. The simultaneous increase in net income and earnings per share over both the quarter and year-to-date periods highlights broad-based operational and financial improvement rather than a one-off gain. Against this backdrop, we will explore...

Atkore entered this quarter with a reputation as a solid electrical infrastructure supplier but was dealing with fresh losses. The stock had already been on a strong run, yet the market’s reaction to Q3 was explosive. Shares jumped about 28% to roughly US$93.55 in regular trading after the release. The headline is not spectacular profit growth; it is that revenue reached about US$794.8m and earnings swung from a heavy recent loss to a small profit of roughly US$0.7m. For a company still...

Bowhead Specialty Holdings just rose 10.1% in a single session, and the mood looks more euphoric than confused. The stock came into the print already riding a strong 90 day run, yet traders still paid up after seeing another solid quarter of underwriting and earnings delivery. Quarterly basic earnings per share of US$0.48, together with revenue of US$163.9m, gave investors enough confidence to lean into the move, even with the trailing P/E already sitting at 17.9x. Impressed by Bowhead...

Easterly Government Properties stock closed up 3.8% today, yet the real story sits inside a quiet but important improvement in its cash engine. For a real estate investment trust, funds from operations matter more than headline earnings, and Q2 delivered US$37.3m of funds from operations alongside US$94.0m of revenue. That combination helped management lift full year core funds from operations per share guidance, a small move on paper that carries outsized weight for investors who focus on...

Interest rate stories rarely stay contained to bond traders. The recent US Japan currency intervention and expanded use of the Fed’s FIMA repo facility have direct implications for US financials and interest rate sensitive sectors, from lenders to real estate and housing related companies. Shifts in Treasury yield pressures and currency flows can change funding costs, balance sheet values and investor appetite. This article walks through 3 US listed stocks from our Financials and Interest...

Goosehead Insurance (GSHD) has drawn fresh attention after reporting second quarter and first half 2026 earnings, along with a planned CEO transition from Mark Miller to current President and COO Mark Jones, Jr., starting in January 2027. See our latest analysis for Goosehead Insurance. The earnings report and CEO succession news arrived after a volatile stretch for Goosehead Insurance, with a 30 day share price return of 24.61% and a 90 day share price return of 59.86%. That recent momentum...

Global trade rules are in flux as the World Trade Organization struggles to deliver fresh agreements, while smaller digital trade deals gain traction. For investors, that mix of uncertainty and targeted reform can change how digital commerce and cross border platforms grow and operate. This article looks at three stocks from our Digital Trade and Ecommerce Sector screener that are particularly exposed to the latest WTO setbacks and the push toward plurilateral agreements. You will see how...

Merck (MRK) is back in focus after MSD Animal Health received European Commission marketing authorization for NOBIVAC NXT HCPChFeLV, a combination feline vaccine that uses RNA particle technology and targets five significant feline pathogens. See our latest analysis for Merck. Merck’s latest product and access announcements come as the stock trades at $130.20, with a 90 day share price return of 16.08% and a 1 year total shareholder return of 69.70%, suggesting momentum has recently been...

With global data sending mixed messages on growth, inflation and manufacturing, healthy high growth potential stocks stand out as a way to focus on company level earnings power rather than short term macro swings. This screener filters for businesses where analysts currently expect strong earnings growth over the next 3 years and where balance sheets and cash flows are in an acceptable condition. That combination of growth outlook and financial resilience can help you focus on quality. In...

Canadian Solar (NasdaqGS:CSIQ) has opened the first phase of its Jeffersonville, Indiana PV cell facility, a key step in reshoring advanced solar manufacturing and expanding its U.S. supply chain footprint. See our latest analysis for Canadian Solar. The Jeffersonville opening comes as Canadian Solar’s share price has climbed 12.96% over the past week but remains down 40.65% year to date, while the 1 year total shareholder return of 33.22% is set against weaker 3 and 5 year total shareholder...

Goodyear has opened its first retail concept store in Detroit, the Goodyear Motor City Garage, a destination-style auto service center that combines tire sales, maintenance services, and brand experiences, first showcased to the public during the 2026 Woodward Dream Cruise weekend. By blending a gathering space for car enthusiasts with a showcase of its technology and heritage, Goodyear is testing an experiential retail format that could influence how it engages directly with consumers and...